| Literature DB >> 15367279 |
Jodi M Smith1, Thomas L Nemeth, Ruth A McDonald.
Abstract
Advances in immunosuppressive therapy over the past decade have led to dramatic improvements in graft survival. The immunosuppression that is used is center-dependent and is constantly evolving with the development of new medications. The goal remains to find the best combination that will optimize graft survival, while minimizing the adverse effects. Copyright 2004 Blackwell MunksgaardMesh：
Substances：
Year: 2004 PMID： 15367279 DOI： 10.1111/j.1399-3046.2004.00209.x
Source DB: PubMed Journal: Pediatr Transplant ISSN： 1397-3142